PE/VC investors

Private Equity (PE) and Venture Capital (VC) investors are the catalysts of innovation and growth in the business world. PE firms primarily target established companies, seeking to optimize operations and unlock value through strategic investments and management expertise. They focus on long-term growth and profitability, often preparing businesses for a future sale or IPO. VC investors, by contrast, are the adventurers of finance, injecting capital into high-potential startups and early-stage companies. They embrace risk for the possibility of outsized returns, often becoming invaluable advisors. Both investor types not only bring capital but also strategic guidance, industry connections, and market insights, propelling their portfolio companies towards success.

Investors (7,384)
Investor
Description
More information
PFH Palladio Holding PFH Palladio Holding
PFH is an independent investment holding, that has operated in Italy for more than 30 years. It has a portfolio of specialized vehicles and provides businesses not only with capital, but also sector expertise. The Group also provides advisory services for extraordinary financial transactions through its subsidiary, Palladio Corporate Finance. Its structure is adaptable, flexible, and elastic, allowing it to approach a wide variety of transactions with the perspective of an advisor or of a direct investor. PFH has a stable capital structure, which blends financial and industrial competencies. The PFH team is solid, cohesive and autonomous, where the managers are also Group partners. Therefore, PFH is not simply a lender, but also a business partner, whose interests are aligned with those of entrepreneurs.
View
Pfizer Ventures Pfizer Ventures
Pfizer Ventures (PV), the venture capital arm of Pfizer Inc., was founded in 2004 and invests for return in areas of current or future strategic interest to Pfizer. PV seeks to remain at the forefront of life science advances, looking to identify and invest in emerging companies that are developing transformative medicines and technologies that have the potential to enhance Pfizer’s pipeline and shape the future of our industry. With a $600M capital commitment from Pfizer for private investments in 2018, PV invests in private companies at all stages of development, with a strong focus on early stage opportunities. Other investments, including start-ups and spinouts, will also be considered. We actively work with our current portfolio companies throughout their growth cycles, contributing strategic guidance in addition to our capital and providing access to internal Pfizer expertise, whenever appropriate. While primarily U.S. focused, international investments may represent up to 20% of the portfolio. We have the ability to lead or join a syndicate of investors and will seek board representation commensurate with our investment. INVESTMENT STRATEGY Primarily focused on potentially transformative therapeutics, with an emphasis on Pfizer's core therapeutic areas (Inflammation & Immunology, Internal Medicine, Oncology, Rare Disease and Vaccines). Focus also includes neuroscience investments, following Pfizer's decision to continue advancing research in this critical area of unmet medical need through a venture capital strategy. Will also consider platform technologies, diagnostics, drug delivery, pharmaceutical services and other technologies that have the potential to transform drug discovery and development. KEY POINTS Active investor, working with management to develop product strategy and build shareholder value. Bring Pfizer pedigree and perspective to our portfolio companies, with the potential to utilize the network and expertise of Pfizer. Streamlined approval process for investment decisions. Potential for Pfizer business development relationship whenever appropriate.
View
PFM Capital, Inc. PFM Capital, Inc.
PFM was established to provide a home grown solution to the lack of capital available for Saskatchewan businesses, aiming to provide companies with the capital required to execute their strategic goals while adding long-term value to the benefit of all stakeholders. Our experience, combined with rigorous due diligence and monitoring standards, has established a strong track record of investment performance and deal flow focused on growth capital, management buyout and expansion financing transactions.
View
PG Impact Investments AG PG Impact Investments AG
We are a global impact investment firm backed by Partners Group, one of the world’s leading private market investment managers. <br />
View
PGIM Real Estate PGIM Real Estate
With $216 billion in gross assets under management and administration (1), PGIM Real Estate provides investors and borrowers access to a range of real estate equity, real estate debt, agriculture, and impact solutions across the risk-return spectrum. PGIM Real Estate is a business of PGIM, the global asset management business of Prudential Financial, Inc. (NYSE: PRU). PGIM Real Estate’s risk management approach, execution capabilities and industry insights are backed by a 50-year legacy of investing in commercial real estate, a 140-year history of real estate financing,(2) and the local experience of professionals in 35 cities globally. Through its investment, financing, asset management, and talent management approach, PGIM Real Estate engages in practices that strive to ignite positive environmental and social impact, while pursuing activities that seek to strengthen communities around the world. Note: No single post regarding an acquisition related to a particular strategy is representative of all investments made by that strategy. Please do not draw inferences regarding the performance of any investment based on the fact that a post references such investment. Past performance is not a guarantee nor a reliable indicator of future results. For Professional Investors only. All investments involve risk, including the possible loss of capital. (1) As of September 30, 2025, net AUM is $139B and AUA is $49B. (2) Includes legacy lending through PGIM’s parent company, PFI.
View
Pharmstandard Ventures Pharmstandard Ventures
Pharmstandard Ventures is a Venture Arm within Pharmstandard, JSC, Russia's leading pharmaceutical company. We were formed in 2013 as Inbio Ventures, and changed our name to Pharmstandard Ventures after corporate restructuring in 2017.
View
Pharos Capital Group Pharos Capital Group
Based in Dallas and Nashville, Pharos Capital Group (www.pharosfunds.com) is a physician-founded private equity firm focused on growing healthcare companies which aim to lower the total cost of care, improve patient outcomes and expand access to care. Since inception, Pharos has invested in 58 companies and currently has over $1 billion of assets under management as of March 31, 2023. Pharos typically invests $25-$50 million in rapidly growing middle market companies seeking later stage funding for internal growth, acquisitions, leveraged buyouts, management buyouts, or recapitalizations.
View
Phaze Ventures Phaze Ventures
Phaze Ventures is a venture capital firm and innovation platform founded to transform the region by unlocking the untapped potential of our youth, start ups and corporates. Headquartered in Oman, our goal is to enable innovation through early stage investments and strategic partnerships. <br /> <br /> ​ <br /> <br /> Our insights are informed by our deep collaborations, network and technical team and our focus is on early stage technology investments from pre-seed to series-A.
View
PHD Equity PHD Equity
PHD Equity Partners is a dedicated independent investment and advisory private equity firm that is owned and controlled by the Partners. We seek to invest in UK businesses with an enterprise value of up to £10m by either opting for a majority or more usually taking a minority stake. <br /> <br /> Our focus is sector wide UK opportunities with an enterprise value of up to £10million. We invest in small and medium-sized businesses, actively working with investee companies to deliver robust and tangible returns for both themselves and our investors. <br /> <br /> The Partners are experienced, seasoned corporate financiers, who as entrepreneurs have a reputation for understanding the challenges of growing a business and the key relationships into the funding arena to creatively structure transactions adding value for all parties. <br /> <br /> Our Partners and Advisory Board Members (comprising of industrialists and entrepreneurs whom have direct experience of managing and growing private companies) have many years of hands-on operations, financial and management experience, which they leverage to help guide entrepreneurial companies grow. <br /> <br /> Private Equity, Securing Investment, MBO, MBIs, Company Sales, Corporate Acquisitions, Development Capital, Debt Advisory, Public to Private, Raising Capital, Equity Release, Cross-border Transactions, Exit Strategy, Financial Due Diligence, Equity Finance, Transaction Services, Forensic Accounting, Management and Strategy, Business Sales.
View
PHI Industrial PHI Industrial
PHI Industrial acquires medium-sized companies in transitional situations and supports the management of the company by means of its own team, with the objective of generating long term value in the companies and guaranteeing their long term success. Generally, the companies are non-core divestments of multinationals or family businesses with no clear succession. We operate across Europe.
View

Investor Database: Find Angel Investors, VCs & Private Equity Firms

Find angel investors, venture capital firms, and private equity investors worldwide.

Search thousands of active investors by stage, industry, and location. Built for founders, fundraising teams, and M&A advisors who need relevant investors fast.

Database at a Glance

  • 7,000+ investors
  • 116 countries covered
  • Angels, venture capital, and private equity in one platform
  • Filter by stage, industry, and location

A Searchable Directory of Active Investors

This is a global investor database built for fast, targeted discovery.

Instead of spreadsheets or generic lists, you can search verified angel investors, venture capital firms, and private equity funds actively investing across markets, industries, and stages.

Everything is structured to help you identify relevant investors quickly and move straight to outreach.

Private Equity List’s AI Search tool lets you describe your company or deal and returns investors with matching investment history, so you are not guessing who might be a fit.

Investor Database With Actionable Data

Every profile is designed to help you assess fit without unnecessary digging.

Each investor profile includes:

  • Investor or firm name
  • Investor type (Angel, Venture Capital, Private Equity)
  • Country and geographic focus
  • Investment stage preference
  • Industry and sector focus

This allows you to shortlist investors based on real criteria, not assumptions.

Global Coverage Across Angels, VC, and Private Equity

The directory supports fundraising and deal sourcing across regions and investor types.

  • Thousands of investors listed worldwide
  • Coverage across multiple countries
  • Angel investors, VC firms, and PE funds in one place
  • Continuously expanding investor coverage

Whether you’re raising early-stage capital or sourcing institutional investors, the database scales with your needs.

Filter Investors by Stage, Industry, and Location

Finding the right investors shouldn’t require manual sorting.

You can filter investors by:

  • Investor type (Angel, VC, Private Equity)
  • Industry and sector
  • Investment stage
  • Country and location

These filters help you focus only on investors aligned with your raise or transaction.

Built for Founders, Fundraising Teams, and Advisors

This investor database is designed for people actively sourcing capital or investors.

Startup Founders

Find investors aligned with your stage, sector, and geography. Build targeted investor lists and reduce time spent on cold outreach.

Fundraising and Growth Teams

Accelerate investor research, improve targeting, and support active fundraising with structured data.

M&A Advisors and Dealmakers

Identify investors and capital partners across regions and deal types. Source active capital faster with better precision.

Search, Shortlist, and Start Outreach

Using the database is straightforward and built for speed.

  1. Search investors using filters for stage, industry, and location
  2. Build a targeted investor shortlist
  3. Begin outreach or deal sourcing

Start Searching Investors Today

Access a global database of angel investors, venture capital firms, and private equity funds built for high-intent fundraising.

Our AI Search tool helps you quickly identify the most relevant investors based on stage, sector, geography, and real investment behaviour.

Search Investors

FAQs

An investor database typically includes structured investment data such as investor type, geographic focus, preferred investment stage, and industry or sector interests.
Yes, most comprehensive investor databases include angel investors alongside venture capital firms, private equity funds, and other early-stage investment sources.
The insight provided depends on how frequently the database is updated, but profiles generally reflect publicly available information on investment focus, stage, and location.
Yes, many investor databases include family office investors, allowing users to identify them by location, investment focus, and deal type.
Investor databases are commonly used by startup founders, fundraising teams, and advisors who need a structured way to research and identify relevant investors.